Watching ALTH and GNTA come back down today, I can only wonder that LJPC and Mr. Linnik's presentation in Vegas went well. Buying in the face of a down market day breaks even? Still, LJPC is dead money and we'll see you at 2.43, or whatever Arch thinks it'll dip back to. Watch the next few days on the above mentioned stocks...supposedly FDA recommendations come out on Fri, and ODAC is Monday in Gaithersburg, MD. GNTA in the morning and ALTH in the afternoon. See the article in WSJ about GNTA speculation in options trading? This could all be played out in similar fashion in August with LJPC. Also, IDEV is due for a hearing at the end of May. An overactive bladder drug is the first drug, but they are holding some good pipeline. BTW, so does LJPC. Snapping up of small biotechs by the big fish could really happen in the near term. IDEV has a marketing agreement that doubles market cap on FDA approval, with the drug currently in use in Europe. Tomorrow should be interesting after such a stinker day today.
Seems to me that GNTA has less of a case than ALTH. My hunch is that both won't get the thumbs up. If you've got a bit of funny money, buy a bit on a flyer. It could have a great upside. I still think ALTH is a smart move, and the price keeps dipping! Try and get in around 4.50 or less.